全体要約
慢性心不全（CHF）デバイス市場は、2022年の売上高を基に、2023年から2029年にかけての地域別および市場セクター別の予測を提供しています。市場は、インプラント型左心補助装置（LVAD）、両心室ペースメーカー、インプラント型除細動器（ICD）などの製品タイプに分かれ、病院、クリニック、家庭などの用途に応じた分析が行われています。
主要な企業には、メドトロニック、アボット、ジョンソン・エンド・ジョンソンなどが含まれ、2022年には上位2社が市場の約%を占めました。市場は、アメリカ、アジア太平洋、ヨーロッパ、中東・アフリカの各地域で成長が見込まれ、特に中国とアメリカの市場が注目されています。
関連する質問
Medtronic, Abbott, Johnson & Johnson, Stanley Pharmaceuticals, New Haven Pharmaceuticals, Inc., Boston Scientific Corporation, HeartWare, Biovail Corporation, Abiomed, Symplmed Pharmaceuticals, Berlin Heart GmbH, ReliantHeart, Inc., Cardiokinetix, Biotronik, Jarvik Heart
製品セグメンテーションのトレンド, 地域別市場の成長機会, 主要企業の戦略と市場シェア
概要
このインサイトレポートは、世界の慢性心不全（CHF）デバイス市場の包括的な分析を提供し、製品セグメンテーション、企業形成、収益、市場シェア、最新の開発、およびM&A活動に関連する重要なトレンドを強調しています。また、慢性心不全（CHF）デバイスのポートフォリオと能力、市場参入戦略、市場ポジション、および地理的な状況に焦点を当てて、主要なグローバル企業の戦略を分析し、加速する世界の慢性心不全（CHF）デバイス市場におけるこれらの企業のユニークな地位をよりよく理解します。
このインサイトレポートは、慢性心不全（CHF）デバイスに関する世界的な展望を形成する主要な市場トレンド、ドライバー、および影響因子を評価し、タイプ、アプリケーション、地理、マーケットサイズ別に予測を分解して、新たなビジネスチャンスを強調します。数百のボトムアップの定性的および定量的な市場入力に基づいた透明な方法論により、この研究の予測は、世界の慢性心不全（CHF）デバイスの現在の状態と将来の軌道について、非常に詳細な見解を提供します。
世界の慢性心不全（CHF）デバイス市場の規模は、2022年のXX米ドルから2029年のXX米ドルに成長することが予測されています。2023年から2029年までのCAGRはXX%の成長が期待されています。
アメリカ合衆国の慢性心不全（CHF）機器市場は、2022年のXX米ドルから2029年までにXX米ドルに増加すると推定されており、2023年から2029年の間にXX%の年平均成長率（CAGR）で成長します。
中国における慢性心不全（CHF）デバイスの市場は、2022年のXX米ドルから2029年のXX米ドルへ増加すると推定されており、2023年から2029年の間でXX%のCAGRが見込まれています。
慢性心不全（CHF）デバイスのヨーロッパ市場は、2022年のXX米ドルから2029年までにXX米ドルに増加すると推定されており、2023年から2029年までの間にXX%のCAGRで成長する見込みです。
グローバルな主要な慢性心不全（CHF）デバイスのプレイヤーには、メドトロニック、アボット、ジョンソン・エンド・ジョンソン、スタンレー・ファーマシューティカルズ、ニューヘブンファーマシューティカルズ社、ボストン・サイエンティフィック・コーポレーション、ハートウェア、ビオヴェイル・コーポレーション、アビオメッドなどが含まれます。収益の観点では、2022年にグローバルで最も大きな2社がほぼXX%のシェアを占めていました。
このレポートは、慢性心不全（CHF）デバイス市場の製品タイプ、アプリケーション、主要メーカー、主要地域および国別の包括的な概要、市場シェア、成長機会を示しています。
市場セグメンテーション
種類別のセグメンテーション
埋め込み型左心室補助装置 (LVAD)
両心室ペースメーカー
植込み型除細動器（ICDs）
持続陽圧呼吸療法装置 (CPAP)
バイレベル陽圧呼吸器 (BiPAP)
心臓ポンプ
アプリケーション別セグメンテーション
病院
クリニック
家庭用
その他
このレポートは、市場を地域別に分割しています。
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下にプロフィールされている企業は、主要な専門家から収集した情報と、企業のカバレッジ、製品ポートフォリオ、市場浸透度を分析して選定されました。
メドトロニック
アボット
ジョンソン・エンド・ジョンソン
スタンレー製薬
ニューへイブンファーマシューティカルズ株式会社
ボストン・サイエンティフィック・コーポレーション
ハートウェア
バイオベール社
アビオメッド
シンプロメッド製薬
ベルリンハート株式会社
リアイアントハート株式会社
カーディオキネティクス
ビオトロニクス
ジャーヴィックハート
この報告書で扱われる重要な質問
グローバル慢性心不全（CHF）デバイス市場の10年間の見通しは何ですか？
慢性心不全（CHF）デバイス市場の成長を促進している要因は何ですか、世界的および地域別に？
市場と地域別で最も早く成長する見込みの技術はどれですか？
慢性心不全（CHF）デバイスの市場機会は、エンド市場の規模によってどのように異なりますか？
慢性心不全（CHF）デバイスは、タイプ、用途にどのように分類されますか？
COVID-19とロシア・ウクライナ戦争の影響は何ですか？
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルの慢性心不全（CHF）デバイス、年間売上、2018年～2029年
2.1.2 慢性心不全（CHF）デバイスの世界市場の現状分析・将来予測、地理別、2018年、2022年および2029年
2.1.3 慢性心不全（CHF）デバイスの世界市場の現状分析・将来予測、国・地域別、2018年、2022年および2029年
2.2 慢性心不全（CHF）デバイスセグメント、タイプ別
2.2.1 植込み型左室補助循環装置（LVAD）
2.2.2 両心室ペースメーカー
2.2.3 植込み型除細動器(ICD)
2.2.4 持続陽圧呼吸器 (CPAP)
2.2.5 バイレベル陽圧呼吸器 (BiPAP)
2.2.6 心臓ポンプ
2.3 慢性心不全（CHF）デバイスの売上、タイプ別
2.3.1 グローバルにおける慢性心不全（CHF）デバイスの売上・市場シェア、タイプ別（2018年～2023年）
2.3.2 慢性心不全（CHF）デバイスのグローバルレベニュー・市場シェア、タイプ別（2018～2023年）
2.3.3 グローバルの慢性心不全（CHF）デバイス、販売価格（タイプ別）（2018年～2023年）
2.4 慢性心不全（CHF）デバイスセグメント、用途別
2.4.1 病院
2.4.2 クリニック
2.4.3 家庭用
2.4.4 その他
2.5 慢性心不全（CHF）デバイスの売上、用途別
2.5.1 グローバルの慢性心不全（CHF）デバイス、収益・市場シェア（用途別）（2018年～2023年）
2.5.2 慢性心不全（CHF）デバイスのグローバルレベニュー・市場シェア、用途別（2018～2023年）
2.5.3 グローバルの慢性心不全（CHF）デバイス、販売価格（用途別）（2018年～2023年）
3 グローバルにおける慢性心不全（CHF）デバイス、企業別
3.1 グローバルにおける慢性心不全（CHF）デバイス市場のブレークダウンデータ、企業別
3.1.1 グローバルにおける慢性心不全（CHF）デバイスの年間売上、企業別（2018年～2023年）
3.1.2 グローバルにおける慢性心不全（CHF）デバイスの売上・市場シェア、企業別（2018年～2023年）
3.2 グローバルにおける慢性心不全（CHF）デバイスの年間収益、企業別（2018年～2023年）
3.2.1 グローバルにおける慢性心不全（CHF）デバイス市場の収益規模、企業別（2018年～2023年）
3.2.2 グローバルにおける慢性心不全（CHF）デバイス市場の収益シェア、企業別（2018年～2023年）
3.3 グローバルにおける慢性心不全（CHF）デバイスの販売価格、企業別
3.4 慢性心不全（CHF）デバイスの主要メーカー、生産地域分布、販売地域、製品タイプ
3.4.1 慢性心不全（CHF）デバイスの主要メーカー、製品と拠点の分布
3.4.2 プレイヤーが提供している慢性心不全（CHF）デバイス製品
3.5 市場集中度分析
3.5.1 競合情勢分析
3.5.2 集中度レシオ（CR3、CR5、CR10）（2018年～2023年）
3.6 新製品・潜在的参入
3.7 M&A、拡大
4 慢性心不全（CHF）デバイスの世界市場過去推移レビュー、地理別
4.1 慢性心不全（CHF）デバイスの世界市場規模の過去推移、地理別（2018年～2023年）
4.1.1 グローバルにおける慢性心不全（CHF）デバイスの年間売上、地理別（2018年～2023年）
4.1.2 グローバルにおける慢性心不全（CHF）デバイスの年間収益、地理別（2018年～2023年）
4.2 慢性心不全（CHF）デバイスの世界市場規模の過去推移、国・地域別（2018年～2023年）
4.2.1 グローバルにおける慢性心不全（CHF）デバイスの年間売上、国・地域別（2018年～2023年）
4.2.2 グローバルにおける慢性心不全（CHF）デバイスの年間収益、国・地域別（2018年～2023年）
4.3 アメリカズにおける慢性心不全（CHF）デバイスの売上成長
4.4 APACにおける慢性心不全（CHF）デバイスの売上成長
4.5 ヨーロッパにおける慢性心不全（CHF）デバイスの売上成長
4.6 中東・アフリカにおける慢性心不全（CHF）デバイスの売上成長
5 アメリカズ
5.1 アメリカズにおける慢性心不全（CHF）デバイスの売上、国別
5.1.1 アメリカズにおける慢性心不全（CHF）デバイスの売上規模、国別（2018年～2023年）
5.1.2 アメリカズにおける慢性心不全（CHF）デバイス市場の収益規模、国別（2018年～2023年）
5.2 アメリカズにおける慢性心不全（CHF）デバイスの売上、タイプ別
5.3 アメリカズにおける慢性心不全（CHF）デバイスの売上、用途別
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおける慢性心不全（CHF）デバイスの売上、地域別
6.1.1 APACにおける慢性心不全（CHF）デバイスの売上規模、地域別（2018年～2023年）
6.1.2 APACにおける慢性心不全（CHF）デバイス市場の収益規模、地域別（2018年～2023年）
6.2 APACにおける慢性心不全（CHF）デバイスの売上、タイプ別
6.3 APACにおける慢性心不全（CHF）デバイスの売上、用途別
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
6.10 中国の台湾
7 ヨーロッパ
7.1 ヨーロッパにおける慢性心不全（CHF）デバイス、国別
7.1.1 ヨーロッパにおける慢性心不全（CHF）デバイスの売上規模、国別（2018年～2023年）
7.1.2 ヨーロッパにおける慢性心不全（CHF）デバイス市場の収益規模、国別（2018年～2023年）
7.2 ヨーロッパにおける慢性心不全（CHF）デバイスの売上、タイプ別
7.3 ヨーロッパにおける慢性心不全（CHF）デバイスの売上、用途別
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカにおける慢性心不全（CHF）デバイス、国別
8.1.1 中東・アフリカにおける慢性心不全（CHF）デバイスの売上規模、国別（2018年～2023年）
8.1.2 中東・アフリカにおける慢性心不全（CHF）デバイス市場の収益規模、国別（2018年～2023年）
8.2 中東・アフリカにおける慢性心不全（CHF）デバイスの売上、タイプ別
8.3 中東・アフリカにおける慢性心不全（CHF）デバイスの売上、用途別
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 製造コスト構造分析
10.1 原料・サプライヤー
10.2 慢性心不全（CHF）デバイスの製造コスト構造分析
10.3 慢性心不全（CHF）デバイスの製造プロセス分析
10.4 慢性心不全（CHF）デバイスのインダストリーチェーン構造
11 マーケティング・流通・顧客
11.1 販売チャネル
11.1.1 直接チャネル
11.1.2 間接チャネル
11.2 慢性心不全（CHF）デバイスの流通業者
11.3 慢性心不全（CHF）デバイスの顧客
12 慢性心不全（CHF）デバイスの世界市場予測レビュー、地理別
12.1 グローバルにおける慢性心不全（CHF）デバイスの市場規模予測、地域別
12.1.1 グローバルの慢性心不全（CHF）デバイス、市場予測（地域別）（2024年～2029年）
12.1.2 グローバルの慢性心不全（CHF）デバイス、年間収益予測（地域別）（2024年～2029年）
12.2 アメリカズにおける予測、国別
12.3 APACにおける予測、地域別
12.4 ヨーロッパにおける予測、国別
12.5 中東・アフリカにおける予測、国別
12.6 グローバルにおける慢性心不全（CHF）デバイスの市場予測、タイプ別
12.7 グローバルにおける慢性心不全（CHF）デバイスの市場予測、用途別
13 キープレイヤー分析
13.1 Medtronic
13.1.1 Medtronic：企業情報
13.1.2 Medtronic：慢性心不全（CHF）デバイス製品ポートフォリオと特徴
13.1.3 Medtronic：慢性心不全（CHF）デバイス売上・収益・価格およびグロスマージン（2018年～2023年）
13.1.4 Medtronic：主要事業概要
13.1.5 Medtronic：直近の展開
13.2 Abbott
13.2.1 Abbott：企業情報
13.2.2 Abbott：慢性心不全（CHF）デバイス製品ポートフォリオと特徴
13.2.3 Abbott：慢性心不全（CHF）デバイス売上・収益・価格およびグロスマージン（2018年～2023年）
13.2.4 Abbott：主要事業概要
13.2.5 Abbott：直近の展開
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson：企業情報
13.3.2 Johnson & Johnson：慢性心不全（CHF）デバイス製品ポートフォリオと特徴
13.3.3 Johnson & Johnson：慢性心不全（CHF）デバイス売上・収益・価格およびグロスマージン（2018年～2023年）
13.3.4 Johnson & Johnson：主要事業概要
13.3.5 Johnson & Johnson：直近の展開
13.4 Stanley Pharmaceuticals
13.4.1 Stanley Pharmaceuticals：企業情報
13.4.2 Stanley Pharmaceuticals：慢性心不全（CHF）デバイス製品ポートフォリオと特徴
13.4.3 Stanley Pharmaceuticals：慢性心不全（CHF）デバイス売上・収益・価格およびグロスマージン（2018年～2023年）
13.4.4 Stanley Pharmaceuticals：主要事業概要
13.4.5 Stanley Pharmaceuticals：直近の展開
13.5 New Haven Pharmaceuticals, Inc
13.6 Boston Scientific Corporation
13.6.1 Boston Scientific Corporation：企業情報
13.6.2 Boston Scientific Corporation：慢性心不全（CHF）デバイス製品ポートフォリオと特徴
13.6.3 Boston Scientific Corporation：慢性心不全（CHF）デバイス売上・収益・価格およびグロスマージン（2018年～2023年）
13.6.4 Boston Scientific Corporation：主要事業概要
13.6.5 Boston Scientific Corporation：直近の展開
13.7 HeartWare
13.7.1 HeartWare：企業情報
13.7.2 HeartWare：慢性心不全（CHF）デバイス製品ポートフォリオと特徴
13.7.3 HeartWare：慢性心不全（CHF）デバイス売上・収益・価格およびグロスマージン（2018年～2023年）
13.7.4 HeartWare：主要事業概要
13.7.5 HeartWare：直近の展開
13.8 Biovail Corporation
13.8.1 Biovail Corporation：企業情報
13.8.2 Biovail Corporation：慢性心不全（CHF）デバイス製品ポートフォリオと特徴
13.8.3 Biovail Corporation：慢性心不全（CHF）デバイス売上・収益・価格およびグロスマージン（2018年～2023年）
13.8.4 Biovail Corporation：主要事業概要
13.8.5 Biovail Corporation：直近の展開
13.9 Abiomed
13.9.1 Abiomed：企業情報
13.9.2 Abiomed：慢性心不全（CHF）デバイス製品ポートフォリオと特徴
13.9.3 Abiomed：慢性心不全（CHF）デバイス売上・収益・価格およびグロスマージン（2018年～2023年）
13.9.4 Abiomed：主要事業概要
13.9.5 Abiomed：直近の展開
13.10 Symplmed Pharmaceuticals
13.10.1 Symplmed Pharmaceuticals：企業情報
13.10.2 Symplmed Pharmaceuticals：慢性心不全（CHF）デバイス製品ポートフォリオと特徴
13.10.3 Symplmed Pharmaceuticals：慢性心不全（CHF）デバイス売上・収益・価格およびグロスマージン（2018年～2023年）
13.10.4 Symplmed Pharmaceuticals：主要事業概要
13.10.5 Symplmed Pharmaceuticals：直近の展開
13.11 Berlin Heart GmbH
13.11.1 Berlin Heart GmbH：企業情報
13.11.2 Berlin Heart GmbH：慢性心不全（CHF）デバイス製品ポートフォリオと特徴
13.11.3 Berlin Heart GmbH：慢性心不全（CHF）デバイス売上・収益・価格およびグロスマージン（2018年～2023年）
13.11.4 Berlin Heart GmbH：主要事業概要
13.11.5 Berlin Heart GmbH：直近の展開
13.12 ReliantHeart, Inc
13.13 Cardiokinetix
13.13.1 Cardiokinetix：企業情報
13.13.2 Cardiokinetix：慢性心不全（CHF）デバイス製品ポートフォリオと特徴
13.13.3 Cardiokinetix：慢性心不全（CHF）デバイス売上・収益・価格およびグロスマージン（2018年～2023年）
13.13.4 Cardiokinetix：主要事業概要
13.13.5 Cardiokinetix：直近の展開
13.14 Biotronik
13.14.1 Biotronik：企業情報
13.14.2 Biotronik：慢性心不全（CHF）デバイス製品ポートフォリオと特徴
13.14.3 Biotronik：慢性心不全（CHF）デバイス売上・収益・価格およびグロスマージン（2018年～2023年）
13.14.4 Biotronik：主要事業概要
13.14.5 Biotronik：直近の展開
13.15 Jarvik Heart
13.15.1 Jarvik Heart：企業情報
13.15.2 Jarvik Heart：慢性心不全（CHF）デバイス製品ポートフォリオと特徴
13.15.3 Jarvik Heart：慢性心不全（CHF）デバイス売上・収益・価格およびグロスマージン（2018年～2023年）
13.15.4 Jarvik Heart：主要事業概要
13.15.5 Jarvik Heart：直近の展開
14 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
This Insight Report provides a comprehensive analysis of the global Chronic Heart Failure (CHF) Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chronic Heart Failure (CHF) Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Chronic Heart Failure (CHF) Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chronic Heart Failure (CHF) Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chronic Heart Failure (CHF) Devices.
The global Chronic Heart Failure (CHF) Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Chronic Heart Failure (CHF) Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Chronic Heart Failure (CHF) Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Chronic Heart Failure (CHF) Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Chronic Heart Failure (CHF) Devices players cover Medtronic, Abbott, Johnson & Johnson, Stanley Pharmaceuticals, New Haven Pharmaceuticals, Inc., Boston Scientific Corporation, HeartWare, Biovail Corporation and Abiomed, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Chronic Heart Failure (CHF) Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Implantable Left Ventricular Assist Device (LVAD)
Biventricular Pacemaker
Implantable Cardioverter-defibrillators (ICDs)
Continuous Positive Air Pressure Device (CPAP)
Bi-level Positive Air Pressure Device (BiPAP)
Heart Pumps
Segmentation by application
Hospital
Clinic
Household
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Abbott
Johnson & Johnson
Stanley Pharmaceuticals
New Haven Pharmaceuticals, Inc.
Boston Scientific Corporation
HeartWare
Biovail Corporation
Abiomed
Symplmed Pharmaceuticals
Berlin Heart GmbH
ReliantHeart, Inc.
Cardiokinetix
Biotronik
Jarvik Heart
Key Questions Addressed in this Report
What is the 10-year outlook for the global Chronic Heart Failure (CHF) Devices market?
What factors are driving Chronic Heart Failure (CHF) Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Chronic Heart Failure (CHF) Devices market opportunities vary by end market size?
How does Chronic Heart Failure (CHF) Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Chronic Heart Failure (CHF) Devices Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Chronic Heart Failure (CHF) Devices by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Chronic Heart Failure (CHF) Devices by Country/Region, 2018, 2022 & 2029
2.2 Chronic Heart Failure (CHF) Devices Segment by Type
2.2.1 Implantable Left Ventricular Assist Device (LVAD)
2.2.2 Biventricular Pacemaker
2.2.3 Implantable Cardioverter-defibrillators (ICDs)
2.2.4 Continuous Positive Air Pressure Device (CPAP)
2.2.5 Bi-level Positive Air Pressure Device (BiPAP)
2.2.6 Heart Pumps
2.3 Chronic Heart Failure (CHF) Devices Sales by Type
2.3.1 Global Chronic Heart Failure (CHF) Devices Sales Market Share by Type (2018-2023)
2.3.2 Global Chronic Heart Failure (CHF) Devices Revenue and Market Share by Type (2018-2023)
2.3.3 Global Chronic Heart Failure (CHF) Devices Sale Price by Type (2018-2023)
2.4 Chronic Heart Failure (CHF) Devices Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Household
2.4.4 Others
2.5 Chronic Heart Failure (CHF) Devices Sales by Application
2.5.1 Global Chronic Heart Failure (CHF) Devices Sale Market Share by Application (2018-2023)
2.5.2 Global Chronic Heart Failure (CHF) Devices Revenue and Market Share by Application (2018-2023)
2.5.3 Global Chronic Heart Failure (CHF) Devices Sale Price by Application (2018-2023)
3 Global Chronic Heart Failure (CHF) Devices by Company
3.1 Global Chronic Heart Failure (CHF) Devices Breakdown Data by Company
3.1.1 Global Chronic Heart Failure (CHF) Devices Annual Sales by Company (2018-2023)
3.1.2 Global Chronic Heart Failure (CHF) Devices Sales Market Share by Company (2018-2023)
3.2 Global Chronic Heart Failure (CHF) Devices Annual Revenue by Company (2018-2023)
3.2.1 Global Chronic Heart Failure (CHF) Devices Revenue by Company (2018-2023)
3.2.2 Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Company (2018-2023)
3.3 Global Chronic Heart Failure (CHF) Devices Sale Price by Company
3.4 Key Manufacturers Chronic Heart Failure (CHF) Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Chronic Heart Failure (CHF) Devices Product Location Distribution
3.4.2 Players Chronic Heart Failure (CHF) Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Chronic Heart Failure (CHF) Devices by Geographic Region
4.1 World Historic Chronic Heart Failure (CHF) Devices Market Size by Geographic Region (2018-2023)
4.1.1 Global Chronic Heart Failure (CHF) Devices Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Chronic Heart Failure (CHF) Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Chronic Heart Failure (CHF) Devices Market Size by Country/Region (2018-2023)
4.2.1 Global Chronic Heart Failure (CHF) Devices Annual Sales by Country/Region (2018-2023)
4.2.2 Global Chronic Heart Failure (CHF) Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas Chronic Heart Failure (CHF) Devices Sales Growth
4.4 APAC Chronic Heart Failure (CHF) Devices Sales Growth
4.5 Europe Chronic Heart Failure (CHF) Devices Sales Growth
4.6 Middle East & Africa Chronic Heart Failure (CHF) Devices Sales Growth
5 Americas
5.1 Americas Chronic Heart Failure (CHF) Devices Sales by Country
5.1.1 Americas Chronic Heart Failure (CHF) Devices Sales by Country (2018-2023)
5.1.2 Americas Chronic Heart Failure (CHF) Devices Revenue by Country (2018-2023)
5.2 Americas Chronic Heart Failure (CHF) Devices Sales by Type
5.3 Americas Chronic Heart Failure (CHF) Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chronic Heart Failure (CHF) Devices Sales by Region
6.1.1 APAC Chronic Heart Failure (CHF) Devices Sales by Region (2018-2023)
6.1.2 APAC Chronic Heart Failure (CHF) Devices Revenue by Region (2018-2023)
6.2 APAC Chronic Heart Failure (CHF) Devices Sales by Type
6.3 APAC Chronic Heart Failure (CHF) Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Chronic Heart Failure (CHF) Devices by Country
7.1.1 Europe Chronic Heart Failure (CHF) Devices Sales by Country (2018-2023)
7.1.2 Europe Chronic Heart Failure (CHF) Devices Revenue by Country (2018-2023)
7.2 Europe Chronic Heart Failure (CHF) Devices Sales by Type
7.3 Europe Chronic Heart Failure (CHF) Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Chronic Heart Failure (CHF) Devices by Country
8.1.1 Middle East & Africa Chronic Heart Failure (CHF) Devices Sales by Country (2018-2023)
8.1.2 Middle East & Africa Chronic Heart Failure (CHF) Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa Chronic Heart Failure (CHF) Devices Sales by Type
8.3 Middle East & Africa Chronic Heart Failure (CHF) Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chronic Heart Failure (CHF) Devices
10.3 Manufacturing Process Analysis of Chronic Heart Failure (CHF) Devices
10.4 Industry Chain Structure of Chronic Heart Failure (CHF) Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Chronic Heart Failure (CHF) Devices Distributors
11.3 Chronic Heart Failure (CHF) Devices Customer
12 World Forecast Review for Chronic Heart Failure (CHF) Devices by Geographic Region
12.1 Global Chronic Heart Failure (CHF) Devices Market Size Forecast by Region
12.1.1 Global Chronic Heart Failure (CHF) Devices Forecast by Region (2024-2029)
12.1.2 Global Chronic Heart Failure (CHF) Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Chronic Heart Failure (CHF) Devices Forecast by Type
12.7 Global Chronic Heart Failure (CHF) Devices Forecast by Application
13 Key Players Analysis
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.1.3 Medtronic Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Abbott
13.2.1 Abbott Company Information
13.2.2 Abbott Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.2.3 Abbott Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Abbott Main Business Overview
13.2.5 Abbott Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.3.3 Johnson & Johnson Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Stanley Pharmaceuticals
13.4.1 Stanley Pharmaceuticals Company Information
13.4.2 Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.4.3 Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Stanley Pharmaceuticals Main Business Overview
13.4.5 Stanley Pharmaceuticals Latest Developments
13.5 New Haven Pharmaceuticals, Inc.
13.5.1 New Haven Pharmaceuticals, Inc. Company Information
13.5.2 New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.5.3 New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 New Haven Pharmaceuticals, Inc. Main Business Overview
13.5.5 New Haven Pharmaceuticals, Inc. Latest Developments
13.6 Boston Scientific Corporation
13.6.1 Boston Scientific Corporation Company Information
13.6.2 Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.6.3 Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Boston Scientific Corporation Main Business Overview
13.6.5 Boston Scientific Corporation Latest Developments
13.7 HeartWare
13.7.1 HeartWare Company Information
13.7.2 HeartWare Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.7.3 HeartWare Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 HeartWare Main Business Overview
13.7.5 HeartWare Latest Developments
13.8 Biovail Corporation
13.8.1 Biovail Corporation Company Information
13.8.2 Biovail Corporation Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.8.3 Biovail Corporation Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Biovail Corporation Main Business Overview
13.8.5 Biovail Corporation Latest Developments
13.9 Abiomed
13.9.1 Abiomed Company Information
13.9.2 Abiomed Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.9.3 Abiomed Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Abiomed Main Business Overview
13.9.5 Abiomed Latest Developments
13.10 Symplmed Pharmaceuticals
13.10.1 Symplmed Pharmaceuticals Company Information
13.10.2 Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.10.3 Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Symplmed Pharmaceuticals Main Business Overview
13.10.5 Symplmed Pharmaceuticals Latest Developments
13.11 Berlin Heart GmbH
13.11.1 Berlin Heart GmbH Company Information
13.11.2 Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.11.3 Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Berlin Heart GmbH Main Business Overview
13.11.5 Berlin Heart GmbH Latest Developments
13.12 ReliantHeart, Inc.
13.12.1 ReliantHeart, Inc. Company Information
13.12.2 ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.12.3 ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 ReliantHeart, Inc. Main Business Overview
13.12.5 ReliantHeart, Inc. Latest Developments
13.13 Cardiokinetix
13.13.1 Cardiokinetix Company Information
13.13.2 Cardiokinetix Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.13.3 Cardiokinetix Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Cardiokinetix Main Business Overview
13.13.5 Cardiokinetix Latest Developments
13.14 Biotronik
13.14.1 Biotronik Company Information
13.14.2 Biotronik Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.14.3 Biotronik Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Biotronik Main Business Overview
13.14.5 Biotronik Latest Developments
13.15 Jarvik Heart
13.15.1 Jarvik Heart Company Information
13.15.2 Jarvik Heart Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.15.3 Jarvik Heart Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Jarvik Heart Main Business Overview
13.15.5 Jarvik Heart Latest Developments
14 Research Findings and Conclusion
List of Tables Table 1. Chronic Heart Failure (CHF) Devices Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions) Table 2. Chronic Heart Failure (CHF) Devices Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions) Table 3. Major Players of Implantable Left Ventricular Assist Device (LVAD) Table 4. Major Players of Biventricular Pacemaker Table 5. Major Players of Implantable Cardioverter-defibrillators (ICDs) Table 6. Major Players of Continuous Positive Air Pressure Device (CPAP) Table 7. Major Players of Bi-level Positive Air Pressure Device (BiPAP) Table 8. Major Players of Heart Pumps Table 9. Global Chronic Heart Failure (CHF) Devices Sales by Type (2018-2023) & (K Units) Table 10. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Type (2018-2023) Table 11. Global Chronic Heart Failure (CHF) Devices Revenue by Type (2018-2023) & ($ million) Table 12. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Type (2018-2023) Table 13. Global Chronic Heart Failure (CHF) Devices Sale Price by Type (2018-2023) & (US$/Unit) Table 14. Global Chronic Heart Failure (CHF) Devices Sales by Application (2018-2023) & (K Units) Table 15. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Application (2018-2023) Table 16. Global Chronic Heart Failure (CHF) Devices Revenue by Application (2018-2023) Table 17. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Application (2018-2023) Table 18. Global Chronic Heart Failure (CHF) Devices Sale Price by Application (2018-2023) & (US$/Unit) Table 19. Global Chronic Heart Failure (CHF) Devices Sales by Company (2018-2023) & (K Units) Table 20. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Company (2018-2023) Table 21. Global Chronic Heart Failure (CHF) Devices Revenue by Company (2018-2023) ($ Millions) Table 22. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Company (2018-2023) Table 23. Global Chronic Heart Failure (CHF) Devices Sale Price by Company (2018-2023) & (US$/Unit) Table 24. Key Manufacturers Chronic Heart Failure (CHF) Devices Producing Area Distribution and Sales Area Table 25. Players Chronic Heart Failure (CHF) Devices Products Offered Table 26. Chronic Heart Failure (CHF) Devices Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) Table 27. New Products and Potential Entrants Table 28. Mergers & Acquisitions, Expansion Table 29. Global Chronic Heart Failure (CHF) Devices Sales by Geographic Region (2018-2023) & (K Units) Table 30. Global Chronic Heart Failure (CHF) Devices Sales Market Share Geographic Region (2018-2023) Table 31. Global Chronic Heart Failure (CHF) Devices Revenue by Geographic Region (2018-2023) & ($ millions) Table 32. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Geographic Region (2018-2023) Table 33. Global Chronic Heart Failure (CHF) Devices Sales by Country/Region (2018-2023) & (K Units) Table 34. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Country/Region (2018-2023) Table 35. Global Chronic Heart Failure (CHF) Devices Revenue by Country/Region (2018-2023) & ($ millions) Table 36. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Country/Region (2018-2023) Table 37. Americas Chronic Heart Failure (CHF) Devices Sales by Country (2018-2023) & (K Units) Table 38. Americas Chronic Heart Failure (CHF) Devices Sales Market Share by Country (2018-2023) Table 39. Americas Chronic Heart Failure (CHF) Devices Revenue by Country (2018-2023) & ($ Millions) Table 40. Americas Chronic Heart Failure (CHF) Devices Revenue Market Share by Country (2018-2023) Table 41. Americas Chronic Heart Failure (CHF) Devices Sales by Type (2018-2023) & (K Units) Table 42. Americas Chronic Heart Failure (CHF) Devices Sales by Application (2018-2023) & (K Units) Table 43. APAC Chronic Heart Failure (CHF) Devices Sales by Region (2018-2023) & (K Units) Table 44. APAC Chronic Heart Failure (CHF) Devices Sales Market Share by Region (2018-2023) Table 45. APAC Chronic Heart Failure (CHF) Devices Revenue by Region (2018-2023) & ($ Millions) Table 46. APAC Chronic Heart Failure (CHF) Devices Revenue Market Share by Region (2018-2023) Table 47. APAC Chronic Heart Failure (CHF) Devices Sales by Type (2018-2023) & (K Units) Table 48. APAC Chronic Heart Failure (CHF) Devices Sales by Application (2018-2023) & (K Units) Table 49. Europe Chronic Heart Failure (CHF) Devices Sales by Country (2018-2023) & (K Units) Table 50. Europe Chronic Heart Failure (CHF) Devices Sales Market Share by Country (2018-2023) Table 51. Europe Chronic Heart Failure (CHF) Devices Revenue by Country (2018-2023) & ($ Millions) Table 52. Europe Chronic Heart Failure (CHF) Devices Revenue Market Share by Country (2018-2023) Table 53. Europe Chronic Heart Failure (CHF) Devices Sales by Type (2018-2023) & (K Units) Table 54. Europe Chronic Heart Failure (CHF) Devices Sales by Application (2018-2023) & (K Units) Table 55. Middle East & Africa Chronic Heart Failure (CHF) Devices Sales by Country (2018-2023) & (K Units) Table 56. Middle East & Africa Chronic Heart Failure (CHF) Devices Sales Market Share by Country (2018-2023) Table 57. Middle East & Africa Chronic Heart Failure (CHF) Devices Revenue by Country (2018-2023) & ($ Millions) Table 58. Middle East & Africa Chronic Heart Failure (CHF) Devices Revenue Market Share by Country (2018-2023) Table 59. Middle East & Africa Chronic Heart Failure (CHF) Devices Sales by Type (2018-2023) & (K Units) Table 60. Middle East & Africa Chronic Heart Failure (CHF) Devices Sales by Application (2018-2023) & (K Units) Table 61. Key Market Drivers & Growth Opportunities of Chronic Heart Failure (CHF) Devices Table 62. Key Market Challenges & Risks of Chronic Heart Failure (CHF) Devices Table 63. Key Industry Trends of Chronic Heart Failure (CHF) Devices Table 64. Chronic Heart Failure (CHF) Devices Raw Material Table 65. Key Suppliers of Raw Materials Table 66. Chronic Heart Failure (CHF) Devices Distributors List Table 67. Chronic Heart Failure (CHF) Devices Customer List Table 68. Global Chronic Heart Failure (CHF) Devices Sales Forecast by Region (2024-2029) & (K Units) Table 69. Global Chronic Heart Failure (CHF) Devices Revenue Forecast by Region (2024-2029) & ($ millions) Table 70. Americas Chronic Heart Failure (CHF) Devices Sales Forecast by Country (2024-2029) & (K Units) Table 71. Americas Chronic Heart Failure (CHF) Devices Revenue Forecast by Country (2024-2029) & ($ millions) Table 72. APAC Chronic Heart Failure (CHF) Devices Sales Forecast by Region (2024-2029) & (K Units) Table 73. APAC Chronic Heart Failure (CHF) Devices Revenue Forecast by Region (2024-2029) & ($ millions) Table 74. Europe Chronic Heart Failure (CHF) Devices Sales Forecast by Country (2024-2029) & (K Units) Table 75. Europe Chronic Heart Failure (CHF) Devices Revenue Forecast by Country (2024-2029) & ($ millions) Table 76. Middle East & Africa Chronic Heart Failure (CHF) Devices Sales Forecast by Country (2024-2029) & (K Units) Table 77. Middle East & Africa Chronic Heart Failure (CHF) Devices Revenue Forecast by Country (2024-2029) & ($ millions) Table 78. Global Chronic Heart Failure (CHF) Devices Sales Forecast by Type (2024-2029) & (K Units) Table 79. Global Chronic Heart Failure (CHF) Devices Revenue Forecast by Type (2024-2029) & ($ Millions) Table 80. Global Chronic Heart Failure (CHF) Devices Sales Forecast by Application (2024-2029) & (K Units) Table 81. Global Chronic Heart Failure (CHF) Devices Revenue Forecast by Application (2024-2029) & ($ Millions) Table 82. Medtronic Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors Table 83. Medtronic Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications Table 84. Medtronic Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 85. Medtronic Main Business Table 86. Medtronic Latest Developments Table 87. Abbott Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors Table 88. Abbott Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications Table 89. Abbott Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 90. Abbott Main Business Table 91. Abbott Latest Developments Table 92. Johnson & Johnson Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors Table 93. Johnson & Johnson Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications Table 94. Johnson & Johnson Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 95. Johnson & Johnson Main Business Table 96. Johnson & Johnson Latest Developments Table 97. Stanley Pharmaceuticals Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors Table 98. Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications Table 99. Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 100. Stanley Pharmaceuticals Main Business Table 101. Stanley Pharmaceuticals Latest Developments Table 102. New Haven Pharmaceuticals, Inc. Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors Table 103. New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications Table 104. New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 105. New Haven Pharmaceuticals, Inc. Main Business Table 106. New Haven Pharmaceuticals, Inc. Latest Developments Table 107. Boston Scientific Corporation Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors Table 108. Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications Table 109. Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 110. Boston Scientific Corporation Main Business Table 111. Boston Scientific Corporation Latest Developments Table 112. HeartWare Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors Table 113. HeartWare Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications Table 114. HeartWare Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 115. HeartWare Main Business Table 116. HeartWare Latest Developments Table 117. Biovail Corporation Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors Table 118. Biovail Corporation Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications Table 119. Biovail Corporation Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 120. Biovail Corporation Main Business Table 121. Biovail Corporation Latest Developments Table 122. Abiomed Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors Table 123. Abiomed Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications Table 124. Abiomed Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 125. Abiomed Main Business Table 126. Abiomed Latest Developments Table 127. Symplmed Pharmaceuticals Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors Table 128. Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications Table 129. Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 130. Symplmed Pharmaceuticals Main Business Table 131. Symplmed Pharmaceuticals Latest Developments Table 132. Berlin Heart GmbH Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors Table 133. Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications Table 134. Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 135. Berlin Heart GmbH Main Business Table 136. Berlin Heart GmbH Latest Developments Table 137. ReliantHeart, Inc. Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors Table 138. ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications Table 139. ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 140. ReliantHeart, Inc. Main Business Table 141. ReliantHeart, Inc. Latest Developments Table 142. Cardiokinetix Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors Table 143. Cardiokinetix Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications Table 144. Cardiokinetix Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 145. Cardiokinetix Main Business Table 146. Cardiokinetix Latest Developments Table 147. Biotronik Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors Table 148. Biotronik Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications Table 149. Biotronik Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 150. Biotronik Main Business Table 151. Biotronik Latest Developments Table 152. Jarvik Heart Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors Table 153. Jarvik Heart Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications Table 154. Jarvik Heart Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 155. Jarvik Heart Main Business Table 156. Jarvik Heart Latest Developments List of Figures Figure 1. Picture of Chronic Heart Failure (CHF) Devices Figure 2. Chronic Heart Failure (CHF) Devices Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Chronic Heart Failure (CHF) Devices Sales Growth Rate 2018-2029 (K Units) Figure 7. Global Chronic Heart Failure (CHF) Devices Revenue Growth Rate 2018-2029 ($ Millions) Figure 8. Chronic Heart Failure (CHF) Devices Sales by Region (2018, 2022 & 2029) & ($ Millions) Figure 9. Product Picture of Implantable Left Ventricular Assist Device (LVAD) Figure 10. Product Picture of Biventricular Pacemaker Figure 11. Product Picture of Implantable Cardioverter-defibrillators (ICDs) Figure 12. Product Picture of Continuous Positive Air Pressure Device (CPAP) Figure 13. Product Picture of Bi-level Positive Air Pressure Device (BiPAP) Figure 14. Product Picture of Heart Pumps Figure 15. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Type in 2022 Figure 16. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Type (2018-2023) Figure 17. Chronic Heart Failure (CHF) Devices Consumed in Hospital Figure 18. Global Chronic Heart Failure (CHF) Devices Market: Hospital (2018-2023) & (K Units) Figure 19. Chronic Heart Failure (CHF) Devices Consumed in Clinic Figure 20. Global Chronic Heart Failure (CHF) Devices Market: Clinic (2018-2023) & (K Units) Figure 21. Chronic Heart Failure (CHF) Devices Consumed in Household Figure 22. Global Chronic Heart Failure (CHF) Devices Market: Household (2018-2023) & (K Units) Figure 23. Chronic Heart Failure (CHF) Devices Consumed in Others Figure 24. Global Chronic Heart Failure (CHF) Devices Market: Others (2018-2023) & (K Units) Figure 25. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Application (2022) Figure 26. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Application in 2022 Figure 27. Chronic Heart Failure (CHF) Devices Sales Market by Company in 2022 (K Units) Figure 28. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Company in 2022 Figure 29. Chronic Heart Failure (CHF) Devices Revenue Market by Company in 2022 ($ Million) Figure 30. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Company in 2022 Figure 31. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Geographic Region (2018-2023) Figure 32. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Geographic Region in 2022 Figure 33. Americas Chronic Heart Failure (CHF) Devices Sales 2018-2023 (K Units) Figure 34. Americas Chronic Heart Failure (CHF) Devices Revenue 2018-2023 ($ Millions) Figure 35. APAC Chronic Heart Failure (CHF) Devices Sales 2018-2023 (K Units) Figure 36. APAC Chronic Heart Failure (CHF) Devices Revenue 2018-2023 ($ Millions) Figure 37. Europe Chronic Heart Failure (CHF) Devices Sales 2018-2023 (K Units) Figure 38. Europe Chronic Heart Failure (CHF) Devices Revenue 2018-2023 ($ Millions) Figure 39. Middle East & Africa Chronic Heart Failure (CHF) Devices Sales 2018-2023 (K Units) Figure 40. Middle East & Africa Chronic Heart Failure (CHF) Devices Revenue 2018-2023 ($ Millions) Figure 41. Americas Chronic Heart Failure (CHF) Devices Sales Market Share by Country in 2022 Figure 42. Americas Chronic Heart Failure (CHF) Devices Revenue Market Share by Country in 2022 Figure 43. Americas Chronic Heart Failure (CHF) Devices Sales Market Share by Type (2018-2023) Figure 44. Americas Chronic Heart Failure (CHF) Devices Sales Market Share by Application (2018-2023) Figure 45. United States Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions) Figure 46. Canada Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions) Figure 47. Mexico Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions) Figure 48. Brazil Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions) Figure 49. APAC Chronic Heart Failure (CHF) Devices Sales Market Share by Region in 2022 Figure 50. APAC Chronic Heart Failure (CHF) Devices Revenue Market Share by Regions in 2022 Figure 51. APAC Chronic Heart Failure (CHF) Devices Sales Market Share by Type (2018-2023) Figure 52. APAC Chronic Heart Failure (CHF) Devices Sales Market Share by Application (2018-2023) Figure 53. China Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions) Figure 54. Japan Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions) Figure 55. South Korea Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions) Figure 56. Southeast Asia Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions) Figure 57. India Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions) Figure 58. Australia Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions) Figure 59. China Taiwan Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions) Figure 60. Europe Chronic Heart Failure (CHF) Devices Sales Market Share by Country in 2022 Figure 61. Europe Chronic Heart Failure (CHF) Devices Revenue Market Share by Country in 2022 Figure 62. Europe Chronic Heart Failure (CHF) Devices Sales Market Share by Type (2018-2023) Figure 63. Europe Chronic Heart Failure (CHF) Devices Sales Market Share by Application (2018-2023) Figure 64. Germany Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions) Figure 65. France Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions) Figure 66. UK Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions) Figure 67. Italy Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions) Figure 68. Russia Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions) Figure 69. Middle East & Africa Chronic Heart Failure (CHF) Devices Sales Market Share by Country in 2022 Figure 70. Middle East & Africa Chronic Heart Failure (CHF) Devices Revenue Market Share by Country in 2022 Figure 71. Middle East & Africa Chronic Heart Failure (CHF) Devices Sales Market Share by Type (2018-2023) Figure 72. Middle East & Africa Chronic Heart Failure (CHF) Devices Sales Market Share by Application (2018-2023) Figure 73. Egypt Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions) Figure 74. South Africa Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions) Figure 75. Israel Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions) Figure 76. Turkey Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions) Figure 77. GCC Country Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions) Figure 78. Manufacturing Cost Structure Analysis of Chronic Heart Failure (CHF) Devices in 2022 Figure 79. Manufacturing Process Analysis of Chronic Heart Failure (CHF) Devices Figure 80. Industry Chain Structure of Chronic Heart Failure (CHF) Devices Figure 81. Channels of Distribution Figure 82. Global Chronic Heart Failure (CHF) Devices Sales Market Forecast by Region (2024-2029) Figure 83. Global Chronic Heart Failure (CHF) Devices Revenue Market Share Forecast by Region (2024-2029) Figure 84. Global Chronic Heart Failure (CHF) Devices Sales Market Share Forecast by Type (2024-2029) Figure 85. Global Chronic Heart Failure (CHF) Devices Revenue Market Share Forecast by Type (2024-2029) Figure 86. Global Chronic Heart Failure (CHF) Devices Sales Market Share Forecast by Application (2024-2029) Figure 87. Global Chronic Heart Failure (CHF) Devices Revenue Market Share Forecast by Application (2024-2029)
